GGrantIndex
Sort

64,565 grants matching drug discovery

Therapeutic Targeting Mitochondrial C1 Metabolism

$614,438
Larry H. Matherly · Wayne State University · R01 · FY2025 · CA

Deciphering the role of histone methyltransferase SETD1A in schizophrenia susceptibility

$614,416
Joseph A Gogos · Columbia University Health Sciences · R01 · FY2017 · MH

Engineering 3D Osteosarcoma Models to Elucidate Biology and Inform Drug Discovery

$614,400
Fan Yang · Stanford University · R01 · FY2024 · CA

DREAM Complex Maintenance of Human Beta Cell Quiescence

$614,378
Andrew F. Stewart · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · DK

DREAM Complex Maintenance of Human Beta Cell Quiescence

$614,378
Andrew F. Stewart · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · DK

DREAM Complex Maintenance of Human Beta Cell Quiescence

$614,378
Andrew F. Stewart · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · DK

Role of Zfp521 in bone formation and anabolic responses

$614,368
Roland E Baron · Harvard Medical School · R01 · FY2011 · AR

Role of Zfp521 in bone formation and anabolic responses

$614,368
Roland E Baron · Harvard Medical School · R01 · FY2012 · AR

Risk Prediction for ER Negative Breast Cancer Recurrence

$614,362
Melissa L Bondy · Baylor College Of Medicine · R01 · FY2016 · CA

Combating Deadly Gram-negative Lung Infections: An Inhalation and Systems Approach

$614,336
Qi Zhou · Purdue University · R01 · FY2018 · AI

Gene Network Identification and Integration (GNetii) Approach to Understanding the Biology Underlying HIV and Drug Abuse.

$614,306
Eric O Johnson · Research Triangle Institute · R01 · FY2022 · DA

The Genetic Basis of Neuroblastoma Tumorigenesis

$614,290
John M Maris · Children'S Hosp Of Philadelphia · R01 · FY2017 · CA

The Genetic Basis of Neuroblastoma Tumorigenesis

$614,290
John M Maris · Children'S Hosp Of Philadelphia · R01 · FY2016 · CA

The Genetic Basis of Neuroblastoma Tumorigenesis

$614,290
John M Maris · Children'S Hosp Of Philadelphia · R01 · FY2015 · CA

Pre-Clinical Testing of the Safety and Efficacy of Treatments for Voice Disorders

$614,288
Bernard Rousseau · Vanderbilt University Medical Center · R01 · FY2017 · DC

G Protein-Coupled Receptor Regulation in Airway Myocytes

$614,288
Raymond B. Penn · Thomas Jefferson University · R01 · FY2019 · HL

A unique strategy for reshaping the antibiotics model: chemokine-inspired therapeutics for targeting the host and pathogen to counter infections caused by multidrug-resistant bacteria

$614,218
Molly A Hughes · University Of Virginia · R01 · FY2024 · AI

Novel Inhibitors to DHPS to Probe Catalytic Mechanism & Therapeutic Potential

$614,066
Stephen W White · St. Jude Children'S Research Hospital · R01 · FY2009 · AI

Small molecule modulators of ΔFosB

$614,032
Gabrielle Rudenko · University Of Texas Med Br Galveston · R01 · FY2024 · DA

Immunoproteasome inhibitors for the treatment of Alzheimers disease

$613,991
Kyung Bo Kim · Florida International University · R01 · FY2025 · AG

Stereoselective Atom Transfer

$613,948
Scripps Research Institute · R01 · FY2004 · GM

NF2-Associated Meningiomas: From Omics Discovery to Targeted Therapy

$613,836
Vijaya Ramesh · Massachusetts General Hospital · R01 · FY2024 · NS

A redox-sensitive switch in the macrophage nucleus regulates acute phaseinflammatory injury

$613,814
Marcelo G. Bonini · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2025 · HL

Investigating a Newly Discovered Aspect of Dopamine Signaling

$613,786
Roshanak Irannejad · University Of California, San Francisco · R01 · FY2025 · DA

Biostatistics Resource

$613,781
Donald A Berry · University Of Tx Md Anderson Can Ctr · P30 · FY2008 · CA